GI
TRVI icon

GAMMA Investing’s Trevi Therapeutics TRVI Stock Holding History

GAMMA Investing’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.76K Buy
193
+94
+95% +$1.62K ﹤0.01% 3862
2026
Q2 		$1.85K Buy
99
+5
+5% +$73 ﹤0.01% 3745
2026
Q1 		$1.12K Sell
94
-86
-48% -$963 ﹤0.01% 3811
2025
Q4 		$2.25K Buy
180
+111
+161% +$1.28K ﹤0.01% 3563
2025
Q3 		$631 Sell
69
-25
-27% -$187 ﹤0.01% 3688
2025
Q2 		$514 Sell
94
-53
-36% -$330 ﹤0.01% 3632
2025
Q1 		$925 Buy
+147
New +$701 ﹤0.01% 3571

Other funds holding TRVI

CD
Chapin Davis Baltimore, Maryland $520M AUM 117.57% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

GAMMA Investing's TRVI Position: Q3 2026 in Review

GAMMA Investing increased its Trevi Therapeutics (TRVI) stake by 95% in Q3 2026, buying an estimated $1.62K and bringing the position to 193 shares worth $2.76K. The position accounts for ﹤0.01% of the portfolio, ranked #3862.

GAMMA Investing first reported a position in TRVI in Q1 2025 and has held it in 7 quarters since. 5 funds tracked by Wall St. Rank hold TRVI as of Q3 2026.

  • GAMMA Investing held 193 shares of Trevi Therapeutics worth $2.76K as of Q3 2026.
  • GAMMA Investing bought 94 Trevi Therapeutics shares in Q3 2026, an estimated $1.62K.
  • Trevi Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3862 holding.
  • GAMMA Investing first reported a position in Trevi Therapeutics in Q1 2025 and has held it in 7 quarters since.
  • 5 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.